INTERACTOR1 | INT1_HGNC_ID | INTERACTOR2 | INT2_HGNC_ID | INTERACTION_TYPE | CSC_METHOD | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | INTERACTION_METHOD | EXPRESSION_LEVEL | PUBMED_ID |
---|
EGR1 | 3238 | SERPINE2 | 8951 | Protein-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay followed by ChIP assay | Up | 31501409
|
STUB1 | 11427 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of STUB1 followed by RT-PCR | Up | 29511337
|
JUN | 6204 | ABCG2 | 74 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by EMSA | NA | 30482236
|
CXCR4 | 2561 | BAG3 | 939 | RNA-Protein Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | RIP assay followed by RT-PCR | NA | 28703799
|
FOXO3 | 3821 | BMI1 | 1066 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay | NA | 31672029
|
SMAD4 | 6770 | CD44 | 1681 | Protein-Gene Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay | NA | 28725489
|
FOXO1 | 3819 | AGO2 | 3263 | RNA-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | RIP assay | NA | 30613295
|
MIR5188 | 43502 | AGO2 | 3263 | RNA-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | RIP assay | NA | 30613295
|
ESR1 | 3467 | FXYD3 | 4027 | Protein-Protein Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay followed by Western Blotting | NA | 28724549
|
SOX9 | 11204 | FXYD3 | 4027 | Protein-Gene Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay | NA | 30482236
|
SRC | 11283 | FXYD3 | 4027 | Protein-Protein Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay followed by Western Blotting | NA | 28724549
|
USP37 | 20063 | GLI1 | 4317 | Protein-Protein Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay | NA | 29422613
|
CEBPD | 1835 | IL6R | 6019 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by qPCR | NA | 30482236
|
CEBPD | 1835 | KLF4 | 6348 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by qPCR | NA | 30274780
|
VEGFA | 12680 | NRP1 | 8004 | Protein-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP followed by Western Blotting | NA | 29179185
|
CEBPD | 1835 | POU5F1 | 9221 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by qPCR | NA | 30206184
|
AGO2 | 3263 | PTBP3 | 10253 | Protein-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay | NA | 29422613
|
CEBPD | 1835 | SOX2 | 11195 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by qPCR | NA | 30233203
|
MYC | 7553 | HDAC5 | 14068 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay | NA | 30206184
|
SOX9 | 11204 | HDAC5 | 14068 | Protein-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Co-IP assay | NA | 28724549
|
CEBPD | 1835 | NANOG | 20857 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by qPCR | NA | 30206184
|
E2F1 | 3113 | NANOG | 20857 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay followed by Western Blotting | NA | 30482232
|
HSPA9 | 5244 | ABCG2 | 74 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of HSPA9 followed by qRT-PCR | Down | 34249423
|
FOXO3 | 3821 | BMI1 | 1066 | Gene-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of FOXO3 followed by qRT-PCR | Down | 31672029
|
WNT10B | 12775 | CD44 | 1681 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
MIR34A | 31635 | CD44 | 1681 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR34A mimics followed by Luciferase Reporter assay | Down | 29187905
|
MIR34A | 31635 | CD44 | 1681 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR34A mimics followed by qRT-PCR | Down | 29187905
|
MIR708 | 33654 | CD47 | 1682 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR708 mimics followed by Luciferase Reporter assay | Down | 31273952
|
MIR210 | 31587 | CDH1 | 1748 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay | Down | 31604679
|
MIR185 | 31556 | E2F1 | 3113 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay followed by RT-PCR | Down | 31286834
|
MIR526B | 32100 | EPAS1 | 3374 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR526B mimics followed by Luciferase Reporter assay and qPCR | Down | 35004266
|
MIR5188 | 43502 | FOXO1 | 3819 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay followed by Western Blotting | Down | 29100291
|
CXCR4 | 2561 | GLI1 | 4317 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of CXCR4 followed by qRT-PCR | Down | 34052833
|
WNT10B | 12775 | HMGA2 | 5009 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
WNT10B | 12775 | INHBB | 6067 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
WNT10B | 12775 | JUN | 6204 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
MIR654 | 32910 | MEF2D | 6997 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR654 mimics followed by Dual Luciferase Reporter assay and qRT-PCR | Down | 35235236
|
WNT10B | 12775 | MET | 7029 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
MIR150 | 31537 | PFN2 | 8882 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR150 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 30628646
|
HSPA9 | 5244 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of HSPA9 followed by qRT-PCR | Down | 34249423
|
CASC15 | 28245 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of CASC15 followed by qRT-PCR | Down | 35235236
|
MIR150 | 31537 | POU5F1 | 9221 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR150 mimics followed by qRT-PCR | Down | 30628646
|
FOXD2-AS1 | 44256 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of FOXD2-AS1 followed by qRT-PCR | Down | 30628646
|
WNT10B | 12775 | PROM1 | 9454 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
MIR130A | 31514 | RAB5B | 9784 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR130A mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 29746865
|
MIR628 | 32884 | SOS1 | 11187 | miRNA-mRNA Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR628 mimics followe by Luciferase Reporter assay | Down | 31604679
|
CASC15 | 28245 | SOX2 | 11195 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of CASC15 followed by qRT-PCR | Down | 35235236
|
MIR150 | 31537 | SOX2 | 11195 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR150 mimics followed by qRT-PCR | Down | 30628646
|
FOXD2-AS1 | 44256 | SOX2 | 11195 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of FOXD2-AS1 followed by qRT-PCR | Down | 30628646
|
MIR30A | 31624 | SOX4 | 11200 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR30A mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 34234874
|
MIR124-1 | 31502 | STAT3 | 11364 | miRNA-mRNA Interaction | FACs for CSC marker | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Dual Luciferase Reporter assay followed by qRT-PCR | Down | 30038266
|
LUCAT1 | 48498 | TCF7L2 | 11641 | RNA-Protein Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | RIP assay followed by qRT-PCR | Down | 30262865
|
MIR6882 | 49928 | TCF7L2 | 11641 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporte assay | Down | 31736268
|
WNT10B | 12775 | TGFB2 | 11768 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424
|
MIR140 | 31527 | WNT1 | 12774 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR140 mimics followed by Luciferase Reporter assay | Down | 31690832
|
CASC15 | 28245 | NANOG | 20857 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of CASC15 followed by qRT-PCR | Down | 35235236
|
MIR150 | 31537 | NANOG | 20857 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR150 mimics followed by qRT-PCR | Down | 30628646
|
FOXD2-AS1 | 44256 | NANOG | 20857 | Gene-Gene Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | SiRNA mediated knockdown of FOXD2-AS1 followed by qRT-PCR | Down | 30628646
|
MIR654 | 32910 | CASC15 | 28245 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR654 mimics followed by Dual Luciferase Reporter assay and qRT-PCR | Down | 35235236
|
MIR6882 | 49928 | SPRY4-IT1 | 42394 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR6882 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 31736268
|
MIR185 | 31556 | LINC00511 | 43564 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay | Down | 31604679
|
MIR150 | 31537 | FOXD2-AS1 | 44256 | miRNA-mRNA Interaction | NA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Transfection with MIR150 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 30628646
|
TCF4 | 11634 | CCAT1 | 45128 | Protein-Gene Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | ChIP assay | Down | 31695775
|
MIR148A | 31535 | CCAT1 | 45128 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay followed by RNA pull down assay | Down | 31695775
|
MIR204 | 31582 | CCAT1 | 45128 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay | Down | 31695775
|
MIR211 | 31588 | CCAT1 | 45128 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Luciferase Reporter assay | Down | 31695775
|
MIR5582 | 43461 | LUCAT1 | 48498 | miRNA-mRNA Interaction | SFA | Luminal A Breast Cancer | Adenocarcinoma | MCF7 | Dual Luciferase Reporter assay followed by RNA pull down assay | Down | 31690832
|